GlucoTrack, Inc. (NASDAQ:GCTK – Get Free Report) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 106,200 shares, an increase of 8.3% from the March 31st total of 98,100 shares. Based on an average trading volume of 169,100 shares, the days-to-cover ratio is […]
GlucoTrack (NASDAQ:GCTK – Get Free Report) is one of 70 public companies in the “Medical Instruments & Supplies” industry, but how does it compare to its competitors? We will compare GlucoTrack to related businesses based on the strength of its valuation, dividends, earnings, risk, analyst recommendations, institutional ownership and profitability. Risk and Volatility GlucoTrack has […]
GlucoTrack (NASDAQ:GCTK – Get Free Report) is one of 224 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it contrast to its peers? We will compare GlucoTrack to similar companies based on the strength of its profitability, dividends, risk, valuation, earnings, institutional ownership and analyst recommendations. Volatility & Risk GlucoTrack has […]
GlucoTrack (NASDAQ:GCTK – Get Free Report) is one of 222 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its peers? We will compare GlucoTrack to related businesses based on the strength of its earnings, risk, profitability, institutional ownership, dividends, analyst recommendations and valuation. Volatility and Risk […]
GlucoTrack (NASDAQ:GCTK – Get Free Report) and Intelligent Bio Solutions (NASDAQ:INBS – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership. Earnings and Valuation This table compares GlucoTrack […]